申请人:MERCK SHARP & DOHME CORP.
公开号:US20160060272A1
公开(公告)日:2016-03-03
The present invention relates to 4-Pyridone Compounds of Formula (I); and pharmaceutically acceptable salts and prodrugs thereof, wherein A, R
1
, R
2
, and R
3
are as defined herein. The present invention also relates to compositions comprising at least one 4-Pyridone Compound, and methods of using the 4-Pyridone Compounds for treating or preventing HIV infection in a subject or the clinical manifestations thereof.